1 The kinetics of action of 17 structurally related NMDA receptor competitive antagonists were measured under voltage clamp in mouse hippocampal neurones. Analysis of the response to rapid changes in antagonist concentration during constant application of agonist was used to estimate microscopic association (k0.) and dissociation (k0ff) rate constants for antagonist binding, assuming a two-equivalent site model for competitive antagonism. Dose-inhibition curves were analysed to estimate antagonist equilibrium dissociation constants.2 For a series of 11 co-phosphono, a-amino acids k03 and k0ff varied 26 and 107 fold respectively. Rapid association and dissociation rate constants were obtained for flexible antagonist molecules such as D-2-amino-7-phosphonoheptanoic acid (D-AP7): k03 1.4 x 17 M-1 -I 1; kff 20.3 s -. For conformationally restrained molecules such as 3S,4aR,6S,8aR-6-phosphonomethyl-decahydroisoquinoline-3-carboxylic acid (LY 235959), association and dissociation rate constants were much slower: k01 1.1 x 106M-1s-1; koff 0.2 s'-. For the D-and L-isomers of 3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) estimates for k0. were similar, but for the L-isomer koff was 10 fold faster than for the D-isomer.3 For 2-amino-5-phosphonopentanoic acid (AP5) and its piperidine derivative cis-44phosphonomethyl) piperidine-2-carboxylic acid (CGS 19755), an increase in chain length of two methylene groups between the co-phosphono and oc-carboxylate moieties caused a 1.6 to 1.8 fold decrease in k0. with little change in koffI In contrast, for AP5, CPP and its co-carboxylate analogue, addition of a double bond close to the phosphonate moiety caused a 1.3 to 1.6 fold increase in k0.. 0 4 For antagonists with an co-tetrazole moiety, k0. and koff were 2.8-4.6 times faster than for the parent co-phosphono compounds. A similar, but smaller increase in k0. and k0ff was observed for antagonists with an co-carboxylate moiety. S The slow kinetics of action of potent NMDA receptor antagonists were not an artefact of buffered diffusion. In neurones equilibrated with 200piM D-AP7, 2puM LY 235959 and 10pM NMDA, a transient agonist response was recorded following a rapid switch to D-AP7-free solution. This can only be explained by differences in the binding kinetics of AP7 and LY 235959, since at equilibrium, with these concentrations, either antagonist essentially eliminates the agonist response to 10puM NMDA. 6 For all antagonists studied, the ratio koff/k0. was agonist binding assays showed only 1.4 fold higher affinity. 7 The insights gained from our experiments may be of use for predicting the structural features required to generate more potent NMDA receptor antagonists, and suggest that novel acyclic compounds will have greater potential for high potency than derivatives of conformationally rigid compounds with piperazine, piperidine or bicyclic ring structures.